genprowebdirectory
Skip to content
Facebook
LinkedIn
RSS
Twitter/X
YouTube
GEN Edge
Featured News
Multimedia
Content
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits & Spotlights
Webinars
GEN Live
Learning Labs
Podcasts
Videos
Resources
A-Lists
eBooks/Perspectives
Tutorials
New Products
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Toggle Search
Search for:
Search
Search
Toggle Mobile Menu
Toggle Search
×
GEN Edge
Expand submenu
Featured News
Multimedia
Content
Expand submenu
News
Insights
Topics
Expand submenu
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Expand submenu
Browse Issues
Subscribe
Multimedia
Expand submenu
Summits & Spotlights
Webinars
GEN Live
Learning Labs
Podcasts
Videos
Resources
Expand submenu
A-Lists
eBooks/Perspectives
Tutorials
New Products
Subscribe
Expand submenu
Get GEN Magazine
Get GEN eNewsletters
×
Search for:
Search
Search
Home
Authors
Posts by Alex Philippidis
Alex Philippidis
House Takes Different Stance from Senate on Two Key Factors in Patent Reform
Translational Research Is the NCATS’ Meow for Growing NIH’s R&D Role
Restructuring and Cuts Threaten to Lower Industry R&D Spending Next Year
Review of the Second Tier of Biotechnology Clusters in the U.S.
FDA Panel Hearing Suggests Medical Professionals May Play Role in Direct-to-Consumer Testing
Stanford v. Roche
Could Place Tech Transfer on Shaky Ground
Patent Reform Likely to Benefit Industry Giants More Than Start-Ups
Overview of the Number Three and Four Biotech Clusters in the U.S.
A Look at the Top Two Bio Clusters in the U.S.: California and Massachusetts
Study Finds a Friend at NIH but Will Congress Share the Love?
<
1
…
165
166
167
Page 167 of 167